HONG KONG'S LI & FUNG CONSIDERS OPTIONS, INCLUDING A SALE, FOR HEALTHCARE ARM IDSMED IN UP TO $500 MLN DEAL - SOURCES
Hong Kong's Li & Fung Considers Options, Including A Sale, For H…
![Reuters logo](/images/reuters.jpg)
HONG KONG'S LI & FUNG CONSIDERS OPTIONS, INCLUDING A SALE, FOR HEALTHCARE ARM IDSMED IN UP TO $500 MLN DEAL - SOURCES